Performing Embryo Transfer: The “Process”

Dr. Geoffrey Sher - November 19, 2018
Performing Embryo Transfer: The “Process”

Embryo transfer (ET) is undoubtedly a rate limiting factor in IVF. The IVF doctor’s expertise in performing ET is one of the most important factors determining IVF outcome. It requires the dexterity, skill, and gentle touch that can only truly come through experience. Of all the procedures in IVF, this is the most difficult to teach. It is a true “art” and there is little doubt that many women will fail to conceive following IVF from a suboptimal transfer technique. Good quality embryos are those whose cells (blastomeres) continue to divide at a regular and predictable rate, such that within 72 hours of fertilization they contain 5-9 cells and within 5-6 days, they will have developed into expanded blastocysts with >100 cells. Such embryos are the ones that are most likely to be “competent” (i.e., able to propagate a pregnancy upon being transferred to a receptive uterus). Conversely, embryos that fail to develop into expanded blastocysts within 5-6 days of being fertilized are almost invariably chromosomally abnormal (aneuploid), “incompetent,”,  and unworthy of transfer. The addition of preimplantation genetic testing/screening  (PGT/PGS) with full embryo karyotyping (which assesses all the embryo’s chromosomes), markedly improves the ability to select truly “competent” embryos for transfer. The select transfer of such PGT/PGS-normal blastocysts, vastly increases the baby rate per embryo transferred, markedly reduces the likelihood of miscarriage, and minimizes the occurrence of chromosomal birth defects such as Down’s syndrome. Shortly before performing ET, the embryos are put together in a single laboratory dish containing growth medium. The laboratory staff informs the clinic coordinator that the embryos are ready for transfer, and the coordinator prepares the patient and informs the physician that a transfer is imminent. Ultrasound Guided Embryo Transfer: A Must!  Embryo transfers should, in our opinion, be performed under direct abdominal ultrasound guidance to ensure proper placement in the uterine cavity. All other factors being equal, such practice, properly conducted, will significantly enhance embryo implantation and pregnancy rates. Optimal Bladder filling to promote visualization: We prefer to perform all embryo transfers with the patient having a full bladder. This tends to straighten the uterus from its normally flexed position, and this better allows entry of the catheter.  In addition, the urine in the bladder allows ultrasound waves to travel better through the body, facilitating clearer visualization of the uterus.  Lastly, a full bladder tends to induce a reflex nervous suppression of uterine contractility, reducing the chance of embryo expulsion. The patient is allowed to empty her bladder 10 minutes following the embryo transfer. Adequate relaxation: It is important that the woman be as relaxed as possible during the embryo transfer because many of the hormones that are released during times of stress, such as adrenalin, can cause the uterus to contract. Accordingly we offer our patients who are prone to high stress levels an oral tranquilizer (e.g. Valium) to take about a half hour prior to the embryo transfer, to reduce apprehension. Some IVF programs believe that imagery helps the woman relax and feel positive about the process and in the process reduce the stress level. In such a program a counselor and/or clinical coordinator may help the woman focus on visual imagery for a few minutes immediately prior to embryo transfer so as to enhance her relaxation. Acupuncture can be relaxing also, and some women find a treatment both before and after treatment helpful. How Many Embryos should be transferred? There is an overriding need to minimize the occurrence of multiple gestations, especially high order multiples (triplets or greater). This is because of the risk of prematurity-related complications increases proportionate to the number of babies in the uterus. Unfortunately, there are several confounding considerations in determining how many embryos to transfer at a time:

  1. The stage of development that the embryos have reached by the time of the ET must also be taken into account in deciding how many to transfer. The reason for this is that blastocysts are far more likely to propagate pregnancies than are cleaved (day 2-3) embryos. So fewer blastocysts need be transferred at a time.
  2. The older the woman who produced the eggs, the greater the likelihood that upon being fertilized, the resulting embryo(s) would be “incompetent.” It follows that the number of embryos that might safely be transferred per IVF procedure (without resulting in a high-order multiple) should be governed by the age of the egg provider. So, while it would be reasonable to restrict the number of “high grade” embryos transferred to a younger woman to one (1) or two (2), the same restriction would be overly stringent for a woman in her mid-40’s receiving embryos derived from the fertilization of their own eggs.
  3. Microscopic grade of the embryos. When a decision on how many embryos to transfer is often based upon the microscopic appearance of such embryos than their microscopic “grade” should be taken into consideration. Since it is less likely for a “lower grade” embryo to foster a healthy pregnancy than a “high grade” embryo, it follows that it would be acceptable to transfer more low-grade embryos at a time than would be considered for “high grade”.
  4. Embryo genetic “competency”. Since an embryo’s “competence” can largely be determined through PGT/PGS, it is highly recommended in the case of PGT/PGS-normal blastocysts to conduct single embryo transfers as a rule, irrespective of maternal age. Each PGT/PGS normal embryo confers approximately a 50-55% chance of fostering a live-birth. The literature also strongly suggest that transferring more than one PGT/PGS normal embryo seems merely to confer a higher risk of twins without appreciably affecting the overall overall pregnancy rate.

The American Society for Reproductive Medicine (ASRM) has taken all these factors into account and has created guidelines for fertility specialists to refer to when determining the number of embryos to transfer. The Embryo Transfer Process: When the woman is in the proper position, and her bladder is adequately filled, the physician first inserts a speculum into the vagina to expose and clean the outer cervix with a sterile saline solution to remove any mucus or other secretions.  An abdominal ultrasound transducer is placed suprapubically on the lower abdomen to allow clear visualization of the uterus. An echogenic embryo transfer cannula (with an empty internal catheter through the entire length of the cervical canal until the sonically activated tip reaches the junction of the cervical canal and uterine cavity. The laboratory is then notified to load a catheter with the embryo (s) to be transferred and deliver them to the treating doctor in the procedure room. At this point the empty catheter is removed from the positioned cannula and the embryo-loaded catheter is passed via the perfectly positioned cannula, to within approximately one (1) centimeter of the top of the uterine cavity, whereupon the embryologist is directed to slowly inject the embryo(s) into the uterus. The passage of the embryos into the uterine cavity can be tracked by ultrasound visualization. A period of 20-- 30 seconds is allowed to elapse, whereupon the catheter and cannula are simultaneously withdrawn slowly. Thereupon, the catheter is immediately returned to the laboratory where it is examined under the microscope to make sure that all the embryos have been released. Any residual embryos would be promptly re-transferred using the same technique. Frozen Embryo Transfers: Available evidence suggests that FET (of previously cryopreserved embryos) is at least as successful as is the transfer of “fresh” embryos and might even have the edge. The probably explanation is certainly unlikely to have anything to do with the freezing process itself. The reason likely has to do with being able to better able to prepare the uterus optimally for embryo implantation by using targeted hormone replacement therapy that when a “fresh” transfer is performed immediately following ovarian stimulation with fertility drugs. We  prefer for our patients to initiate FET cycles with oral contraceptive (OC) starting within 5-6 days of the start of menses to the recipient. This is later overlapped with a GnRH agonist such as Lupron  daily for 5-6 days. The OC is then withdrawn, but the daily Lupron injections are continued until the onset of menstruation. Next, the Lupron dosage is reduced and intramuscular (IM) estradiol valuate (Delestrogen) is administered every 3 days. The objective of the estradiol is to achieve and sustain an optimal plasma E2 concentration of 500- 1000 pg/ml and an 8mm+ endometrial lining as assessed by ultrasound examination. Intramuscular and/or intravaginal progesterone is administered daily starting about 6 days prior to the FET and continued along with twice weekly IM Delestrogen until the 11th week of pregnancy or until it has been confirmed that the patient is not pregnant. Daily oral dexamethasone commences with the Lupron start and continues until a negative pregnancy test or until the completion of the 8th week of pregnancy. Then it is tapered down and discontinued. The recipient also receives prophylactic oral antibiotics starting with the initiation of progesterone therapy, until the day after ET. Usually we would thaw vitrified blastocysts with the objective of having at least one for transfer. Commencing on the day following the ET, the patient inserts a vaginal progesterone suppository daily and this is continued until the completion of the 11th week of pregnancy or until a negative pregnancy test. An alternative regimen for women who cannot tolerate intramuscular Progesterone (PIO), is to supplant this with daily vaginal Crinone 8% or Endometrin inserts. Blood pregnancy tests are performed 8 and 10 days after the embryo transfer. Immediately prior to being discharged following the embryo transfer procedure, an exit interview is conducted whereby the patient is given post- transfer instructions and a medication calendar. The patient’s partner or companion is certainly welcome to be present for the whole process.


Ask a question or post a comment

Your email address will not be published. Required fields are marked *.

Begin Your Fertility Journey

Sher Fertility Solutions is here to help you create your family.

Book A Consultation

Contact

Sher Fertility Solutions
425 5th Ave.
New York, NY 10016

Dr. Tortoriello (646)792-7476
Dr. Sher (702)533-2691

Connect